Notice of Intent to Publish a Funding Opportunity Announcement for NCI Cancer Screening Research Network: Statistics and Data Management Center (UG1 Clinical Trial Required)
Notice NOT-CA-22-130 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 28, 2022 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for NCI Cancer Screening Research Network: ACCrual, Enrollment, and Screening Sites (ACCESS) Hub (UG1 Clinical Trial Required)
Notice NOT-CA-22-129 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 28, 2022 Category: Research Source Type: funding
Notice of Change to PAR-22-162, "Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
Notice NOT-CA-22-134 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 28, 2022 Category: Research Source Type: funding
Notice of Change to PAR-22-161, "Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed)
Notice NOT-CA-22-133 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 28, 2022 Category: Research Source Type: funding
Notice of Early Expiration of PAR-21-335 "Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)"
Notice NOT-CA-22-128 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 19, 2022 Category: Research Source Type: funding
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
The objective of this award is to facilitate a timely transition of these fellows from their mentored, postdoctoral research positions to independent tenure-track (or equivalent) faculty positions. The program will provide independent NCI research support during this transition to help awardees to launch competitive, independent research careers. Researchers in the scientific areas of data science and cancer control science are especially encouraged to apply. This Funding Opportunity Announcement (FOA) is designed specifically for candidates proposing to serve as the lead investigator of an independent clinical trial, a cl...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 15, 2022 Category: Research Source Type: funding
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
The objective of this award is to facilitate a timely transition of these fellows from their mentored, postdoctoral research positions to independent tenure-track (or equivalent) faculty positions. The program will provide independent NCI research support during this transition to help awardees to launch competitive, independent research careers. Researchers in the scientific areas of data science and cancer control science are especially encouraged to apply. This Funding Opportunity Announcement (FOA) is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 15, 2022 Category: Research Source Type: funding
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)
The objective of this award is to facilitate a timely transition of these fellows from their mentored, postdoctoral research positions to independent tenure-track (or equivalent) faculty positions. The program will provide independent NCI research support during this transition to help awardees to launch competitive, independent research careers. Researchers in the scientific areas of data science and cancer control science are especially encouraged to apply. This Funding Opportunity Announcement (FOA) is designed specifically for candidates proposing to serve as the lead investigator of an independent clinical trial, a cl...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 15, 2022 Category: Research Source Type: funding
Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-22-055 from the NIH Guide for Grants and Contracts. The overall goal of this FOA is to establish an agile and effective network infrastructure that undertakes collaborative research to discover molecularly or immunologically targeted agents designed to prevent or intercept oncogenic process in high-risk populations for precision cancer prevention and interception. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 13, 2022 Category: Research Source Type: funding
Dear Colleague Letter: Submission of Proposals to NSF Programs that Address the Interdisciplinary Topics of Theoretical Physics Approaches to Aging, Cancer Biology, and Neurodegenerative Disorders
Available Formats: HTML: https://www.nsf.gov/pubs/2022/nsf22119/nsf22119.jsp?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2022/nsf22119/nsf22119.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf22119Public Comment: This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - September 8, 2022 Category: Science Source Type: funding
Request for Information (RFI): Seeking Input for the National Cancer Institute (NCI) on Expanding the Development of the Integrated Canine Data Commons
Notice NOT-CA-22-125 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 6, 2022 Category: Research Source Type: funding
NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional)
Funding Opportunity RFA-CA-22-050 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports the Cancer Moonshot Scholars Diversity Program (CMSDP) and solicits R01 grant applications that propose independent research projects within the scientific mission of the National Cancer Institute (NCI). The overarching goal of the CMSDP is to increase the number of R01 Early Stage Investigators (ESIs) awardees from underrepresented groups (URGs), while promoting scientific advancements through diversification of NCIs investigator pool. Investigators from diverse backgrounds, including thos...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 1, 2022 Category: Research Source Type: funding
Pre-Application Webinar for RFA-CA-22-019, Global Implementation Science for Equitable Cancer Control (GlobalISE Cancer Control, U54 Clinical Trial Optional)
Notice NOT-CA-22-124 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 30, 2022 Category: Research Source Type: funding
Notice of Pre-application Webinar for Cancer Adoptive Cellular Therapy Network (Can-ACT) for Adult (RFA-CA-22-028) and Pediatric Cancers (RFA-CA-22-029), and Coordinating Center (RFA-CA-22-030)
Notice NOT-CA-22-123 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 29, 2022 Category: Research Source Type: funding
Cancer Adoptive Cellular Therapy Network (Can-ACT) for Adult Cancers (UG3/UH3 Clinical Trial Required)
Funding Opportunity RFA-CA-22-028 from the NIH Guide for Grants and Contracts. The National Cancer Institute (NCI) intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) soliciting UG3/UH3 applications for the Cancer Adoptive Cellular Therapy (Can-ACT) Network. The goal of this collaborative research network will be to stimulate the conduct of early adoptive cellular therapy clinical trials for adult and pediatric solid tumors. The emphasis is on accelerating the advancement of new cell therapy strategies into clinical testing through novel and collaborative approaches to preclinical ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 24, 2022 Category: Research Source Type: funding
